Cargando…

The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial

BACKGROUND: Differences in effectiveness and tolerability between different atypical antipsychotics may affect schizophrenic patients’ treatment adherence or prognosis. However, which kind of antipsychotic was more effective and safe in the treatment of schizophrenia is still being debated. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Congjie, Shi, Wenjie, Huang, Chengbing, Zhu, Jiannan, Huang, Wenzhong, Chen, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740943/ https://www.ncbi.nlm.nih.gov/pubmed/29299043 http://dx.doi.org/10.1186/s12991-017-0170-2

Ejemplares similares

Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial
por: Wang, Congjie, et al.
Publicado: (2020)

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
por: Wei, Qianqian, et al.
Publicado: (2022)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Grošić, Vladimir, et al.
Publicado: (2014)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
por: Kirino, Eiji
Publicado: (2017)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia
por: Zhao, Na, et al.
Publicado: (2021)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model
por: Furiak, Nicolas M, et al.
Publicado: (2012)

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2012)

Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment
por: Li, Wenbin, et al.
Publicado: (2018)

Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison
por: Roh, Daeyoung, et al.
Publicado: (2015)

Impaired interactions among white‐matter functional networks in antipsychotic‐naive first‐episode schizophrenia
por: Fan, Yun‐Shuang, et al.
Publicado: (2019)

Magnetization transfer imaging alterations and its diagnostic value in antipsychotic-naïve first-episode schizophrenia
por: Lei, Du, et al.
Publicado: (2022)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method
por: Randau, M., et al.
Publicado: (2019)

Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study
por: Bahta, Merhawi, et al.
Publicado: (2021)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia
por: Li, Zongchang, et al.
Publicado: (2015)

Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology
por: Bak, N, et al.
Publicado: (2017)

Reduced Levels and Disrupted Biosynthesis Pathways of Plasma Free Fatty Acids in First-Episode Antipsychotic-Naïve Schizophrenia Patients
por: Zhou, Xiang, et al.
Publicado: (2020)

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu, Chengcheng, et al.
Publicado: (2020)

Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study
por: Wijesundera, Hiranya, et al.
Publicado: (2014)

Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophrenia
por: Venkatasubramanian, Ganesan
Publicado: (2010)

Thalamic Shape Abnormalities in Antipsychotic Naïve Schizophrenia
por: Danivas, Vijay, et al.
Publicado: (2013)

Entorhinal Cortex Volume in Antipsychotic-naïve Schizophrenia
por: Jose, Sam P., et al.
Publicado: (2012)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

Effects of comorbid alcohol use disorder on the clinical outcomes of first-episode schizophrenia: a nationwide population-based study
por: Ahn, Soojin, et al.
Publicado: (2021)

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls
por: Batalla, A, et al.
Publicado: (2015)

S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Modular architecture and resilience of structural covariance networks in first-episode antipsychotic-naive psychoses
por: Lewis, Madison, et al.
Publicado: (2023)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
por: Sun, Qiaoling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bod8g0hfgpo257ekf2vg495g0g